Genetically engineered grains are mainstream, but gene splicing in livestock remains experimental. A Boston area biotechnology firm hopes to change that and end its 18-year quest for commercial approval.
Growth in emerging markets is driving activity, despite the need for manufacturers to tackle economic challenges, cut costs, ensure operational efficiency and decrease environmental impact.